TY - JOUR
T1 - Omega-3 fatty acids in adipose tissue and risk of myocardial infarction
T2 - The EURAMIC study
AU - Guallar, Eliseo
AU - Aro, Antti
AU - Jiménez, F. Javier
AU - Martín-Moreno, José M.
AU - Salminen, Irma
AU - Van't Veer, Pieter
AU - Kardinaal, Alwine F.M.
AU - Gömez-Aracena, Jorge
AU - Martin, Biaise C.
AU - Kohlmeier, Lenore
AU - Kark, Jeremy D.
AU - Mazaev, Vladimir P.
AU - Ringstad, Jetmund
AU - Guillén, José
AU - Riemersma, Rudolph A.
AU - Huttunen, Jussi K.
AU - Thamm, Michael
AU - Kok, Frans J.
PY - 1999/4
Y1 - 1999/4
N2 - Omega-3 fatty acids have potential antiatherogenic, antithrombotic, and antiarrhythmic properties, but their role in coronary heart disease remains controversial. To evaluate the association of omega-3 fatty acids in adipose tissue with the risk of myocardial infarction in men, a case-control study was conducted in eight European countries and Israel. Cases (n=639) included patients with a first myocardial infarction admitted to coronary care units within 24 hours from the onset of symptoms. Controls (n=700) were selected to represent the populations originating the cases. Adipose tissue levels of fatty acids were determined by capillary gas chromatography. The mean (±SD) proportion of α-linolenic acid was 0.77% (±0.19) of fatty acids in cases and 0.80% (±0.19) of fatty acids in controls (P=0.01). The relative risk for the highest quintile of α-linolenic acid compared with the lowest was 0.42 (95% confidence interval [CI] 0.22 to 0.81, P-trend=0.02). After adjusting for classical risk factors, the relative risk for the highest quintile was 0.68 (95% CI 0.31 to 1.49, P-trend=0.38). The mean proportion of docosahexaenoic acid was 0.24% (±0.13) of fatty acids in cases and 0.25% (±0.13) of fatty acids in controls (P=0.14), with no evidence of association with risk of myocardial infarction. In this large case-control study we could not detect a protective effect of docosahexaenoic acid on the risk of myocardial infarction. The protective effect of α-linolenic acid was attenuated after adjusting for classical risk factors (mainly smoking), but it deserves further research.
AB - Omega-3 fatty acids have potential antiatherogenic, antithrombotic, and antiarrhythmic properties, but their role in coronary heart disease remains controversial. To evaluate the association of omega-3 fatty acids in adipose tissue with the risk of myocardial infarction in men, a case-control study was conducted in eight European countries and Israel. Cases (n=639) included patients with a first myocardial infarction admitted to coronary care units within 24 hours from the onset of symptoms. Controls (n=700) were selected to represent the populations originating the cases. Adipose tissue levels of fatty acids were determined by capillary gas chromatography. The mean (±SD) proportion of α-linolenic acid was 0.77% (±0.19) of fatty acids in cases and 0.80% (±0.19) of fatty acids in controls (P=0.01). The relative risk for the highest quintile of α-linolenic acid compared with the lowest was 0.42 (95% confidence interval [CI] 0.22 to 0.81, P-trend=0.02). After adjusting for classical risk factors, the relative risk for the highest quintile was 0.68 (95% CI 0.31 to 1.49, P-trend=0.38). The mean proportion of docosahexaenoic acid was 0.24% (±0.13) of fatty acids in cases and 0.25% (±0.13) of fatty acids in controls (P=0.14), with no evidence of association with risk of myocardial infarction. In this large case-control study we could not detect a protective effect of docosahexaenoic acid on the risk of myocardial infarction. The protective effect of α-linolenic acid was attenuated after adjusting for classical risk factors (mainly smoking), but it deserves further research.
KW - Adipose tissue
KW - Case- control studies
KW - Docosahexaenoic acid
KW - Myocardial infarction
KW - α-linolenic acid
UR - http://www.scopus.com/inward/record.url?scp=0032919834&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032919834&partnerID=8YFLogxK
U2 - 10.1161/01.ATV.19.4.1111
DO - 10.1161/01.ATV.19.4.1111
M3 - Article
C2 - 10195943
AN - SCOPUS:0032919834
SN - 1079-5642
VL - 19
SP - 1111
EP - 1118
JO - Arteriosclerosis, thrombosis, and vascular biology
JF - Arteriosclerosis, thrombosis, and vascular biology
IS - 4
ER -